Intracellular Th (ITCI)
US$ 131.87-0.03%
Price Chart
Key Statistics
Market Cap
$ 14.05B
P/E Ratio
0.00
Revenue (TTM)
$ 680.85M
Volume
15.74M
52W High
$ 131.98
52W Low
$ 67.68
Dividend Yield
0.00%
Beta
0.46
Technicals
50-Day MA
129.3384
200-Day MA
93.1161
52 Week High
131.98
52 Week Low
67.68
About ITCI
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and ne.
Employees
860
Headquarters
Bedminster, NJ
CEO
Dr. Sharon Mates Ph.D.
Latest News
J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC
2025-01-13 • Google News
How To Trade (ITCI) - news.stocktradersdaily.com
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg